Current Edition

news

Prestige Biopharma and Alvogen Announce License and Supply Agreement to Commercialize Prestige´s Trastuzumab Biosimilar (Hervelous™) in Central and Eastern Europe Singapore

Prestige BioPharma and Alvogen today announced that the two companies have entered into a binding agreement for the exclusive partnership and supply for the commercialization …

Continue Reading →
news

Alpha Biopharma announces series A financing

 AZD3759, AlphaBio’s lead product, is a next-generation small molecule tyrosine kinase inhibitor (TKI). It is specifically designed to treat epidermal growth factor receptor (EGFR) mutation …

Continue Reading →
news

Wize Pharma signs distribution agreement in China for LO2A

HPGC is a division of Harbin Pharmaceutical Group Co. Ltd., one of China’s largest healthcare companies with 20,000 employees and assets worth $2.9 billion. Wize …

Continue Reading →
news

Johnson & Johnson has the most bucks for biopharma M&A, Astellas the easiest target: analyst

The $62 billion Takeda-Shire deal surprised everyone—and worries some—as Takeda is borrowing an enormous $31 billion to help pay for the purchase. Does it refresh the …

Continue Reading →
LOGO-BiopharmaGroup-V30816-e1484920436795
A-D

Biopharma Group

The Biopharma Group comprises of Biopharma Process Systems (BPS), Biopharma Technologies Ltd (BTL), Biopharma Technology LLC (USA) and Biopharma Technologies France (BTF). Equipment Sales & Service Division: BPS …

Continue Reading →